8-AZASPIRO[BICYCLO[3.2.1]OCTANE-3,2'-[1,3]DIOXOLANE], 95.0%, 250mg

Ethyl 4-bromo-6-fluoropyrazolo[1,5-a]pyridine-3-carboxylate, 95%, 100mg

3-(cyclopropylmethyl)-1H-pyrazol-5-amine, 100mg

ethyl [(5-chloroquinolin-8-yl)oxy]acetate, 98%, 25mg

3-(4-Bromo-2-trifluoromethyl-phenyl)-2-cyano-propionamide, 95.0%, 1g

1-(1-Methyl-1H-imidazol-5-yl)ethanone, 95.0%, 250mg

tert-Butyl 3-(2-(tert-butoxy)-2-oxoethyl)-4-oxopiperidine-1-carboxylate, 95.0%, 250mg

1-(5-Carboxypentyl)-2,3,3-trimethyl-3H-indol-1-ium bromide, 95.0%, 250mg

3,3-Diethoxypropanoic acid, 95.0%, 5g

1-[(4S)-4-(1-Methylethyl)-2-thioxo-3-oxazolidinyl]-1-propanone, 97%, 250mg

4-Bromo-2,5-difluorobenzonitrile, 95.0%, 10g

3-(1-((3,3-Diphenylpropyl)(methyl)amino)-2-methylpropan-2-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate hydrochloride, 99+%, 25g

Acide indole-3-acétique, min 99 %, pour la biochimie, 50 g, emballage plastique.